Cargando…

Residual Cardiovascular Risk in Individuals on Blood Pressure–Lowering Treatment

BACKGROUND: Hypertensive individuals on blood pressure (BP)–lowering treatment with BP in the normal or high‐normal range have higher cardiovascular risk than untreated persons with usual BP in the same range. This residual risk (relative and absolute) is not well quantified and may be attributable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lieb, Wolfgang, Enserro, Danielle M., Sullivan, Lisa M., Vasan, Ramachandran S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845218/ https://www.ncbi.nlm.nih.gov/pubmed/26588944 http://dx.doi.org/10.1161/JAHA.115.002155

Ejemplares similares

Residual cardiovascular risk in individuals on lipid-lowering treatment: quantifying absolute and relative risk in the community
por: Lieb, Wolfgang, et al.
Publicado: (2018)

Twenty‐Year Trends in the American Heart Association Cardiovascular Health Score and Impact on Subclinical and Clinical Cardiovascular Disease: The Framingham Offspring Study
por: Enserro, Danielle M., et al.
Publicado: (2018)

Scientific Contributions of Population-Based Studies to Cardiovascular Epidemiology in the GWAS Era
por: Lieb, Wolfgang, et al.
Publicado: (2018)

Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association With Cardiovascular Disease and Mortality in the Framingham Heart Study
por: Haring, Robin, et al.
Publicado: (2016)

Implications of the US Cholesterol Guidelines on Eligibility for Statin Therapy in the Community: Comparison of Observed and Predicted Risks in the Framingham Heart Study Offspring Cohort
por: Andersson, Charlotte, et al.
Publicado: (2015)

Association of Parental Obesity and Diabetes Mellitus With Circulating Adipokines in Nonobese Nondiabetic Offspring
por: Zachariah, Justin P., et al.
Publicado: (2017)

Plasma Leptin Levels and Incidence of Heart Failure, Cardiovascular Disease, and Total Mortality in Elderly Individuals
por: Lieb, Wolfgang, et al.
Publicado: (2009)

Premature Parental Cardiovascular Disease and Subclinical Disease Burden in the Offspring
por: Lieb, Wolfgang, et al.
Publicado: (2020)

Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data
por: Karmali, Kunal N., et al.
Publicado: (2018)

The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives
por: Barreto, Joaquim, et al.
Publicado: (2023)

Association of Blood Pressure Responses to Submaximal Exercise in Midlife With the Incidence of Cardiovascular Outcomes and All‐Cause Mortality: The Framingham Heart Study
por: Lee, Joowon, et al.
Publicado: (2020)

Association of antecedent cardiovascular risk factor levels and trajectories with cardiovascular magnetic resonance-derived cardiac function and structure
por: Lorbeer, Roberto, et al.
Publicado: (2021)

Circulating Brain‐Derived Neurotrophic Factor Concentrations and the Risk of Cardiovascular Disease in the Community
por: Kaess, Bernhard M., et al.
Publicado: (2015)

Differences in estimates for 10-year risk of cardiovascular disease in Black versus White individuals with identical risk factor profiles using pooled cohort equations: an in silico cohort study
por: Vasan, Ramachandran S, et al.
Publicado: (2022)

Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis
por: Pinho-Gomes, Ana-Catarina, et al.
Publicado: (2021)

Identifying Individuals at Risk for Cardiovascular Events Across the Spectrum of Blood Pressure Levels
por: Karmali, Kunal N, et al.
Publicado: (2015)

Blood pressure values and depression in hypertensive individuals at high cardiovascular risk
por: Mejia-Lancheros, Cilia, et al.
Publicado: (2014)

Left Ventricular Diastolic Dysfunction in the Community: Impact of Diagnostic Criteria on the Burden, Correlates, and Prognosis
por: Nayor, Matthew, et al.
Publicado: (2018)

Association of Circulating Tissue Inhibitor of Metalloproteinases‐1 and Procollagen Type III Aminoterminal Peptide Levels With Incident Heart Failure and Chronic Kidney Disease
por: Lieb, Wolfgang, et al.
Publicado: (2019)

Assessment of Visit‐to‐Visit Blood Pressure Variability in Adults With Optimal Blood Pressure: A New Player in the Evaluation of Residual Cardiovascular Risk?
por: Liu, Menghui, et al.
Publicado: (2022)

Intensive Blood Pressure Treatment Does Not Improve Cardiovascular Outcomes in Centrally Obese Hypertensive Individuals With Diabetes: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial
por: Barzilay, Joshua I., et al.
Publicado: (2012)

Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All‐Cause Mortality: Observations From the Framingham Study Over 35 Years
por: Duncan, Meredith S., et al.
Publicado: (2019)

Primary prevention of cardiovascular disease: The past, present, and future of blood pressure- and cholesterol-lowering treatments
por: Leening, Maarten J. G., et al.
Publicado: (2018)

Influence of Time of Day of Blood Pressure–Lowering Treatment on Cardiovascular Risk in Hypertensive Patients With Type 2 Diabetes
por: Hermida, Ramón C., et al.
Publicado: (2011)

Can Ambulatory Blood Pressure Variability Contribute to Individual Cardiovascular Risk Stratification?
por: Magdás, Annamária, et al.
Publicado: (2016)

Legacy Effect of Delayed Blood Pressure-Lowering Pharmacotherapy in Middle-Aged Individuals Stratified by Absolute Cardiovascular Disease Risk: Protocol for a Systematic Review
por: Ho, Chau Le Bao, et al.
Publicado: (2017)

Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
Publicado: (2021)

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
Publicado: (2021)

Blood pressure lowering treatment and the Framingham score: Do not fear risk
por: Brouwer, Tom F., et al.
Publicado: (2019)

Blood Pressure and Control of Cardiovascular Risk
por: Whitworth, Judith A
Publicado: (2005)

Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril
por: Wang, Ji-Guang, et al.
Publicado: (2014)

Lifetime Risk of Cardiovascular Disease Among Individuals With and Without Diabetes Stratified by Obesity Status in the Framingham Heart Study
por: Fox, Caroline S., et al.
Publicado: (2008)

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis
por: Nazarzadeh, Milad, et al.
Publicado: (2022)

Blood Pressure and the Risk of Developing Diabetes in African Americans and Whites: ARIC, CARDIA, and the Framingham Heart Study
por: Wei, Gina S., et al.
Publicado: (2011)

Association of orthostatic blood pressure response with incident heart failure: The Framingham Heart Study
por: Shrout, Tara A., et al.
Publicado: (2022)

Regional grey matter shrinks in hypertensive individuals despite successful lowering of blood pressure
por: Jennings, J. R., et al.
Publicado: (2011)

Improving cardiovascular health in women & children around the world
por: Xanthakis, Vanessa, et al.
Publicado: (2012)

Erythrocyte n-6 Fatty Acids and Risk for Cardiovascular Outcomes and Total Mortality in the Framingham Heart Study
por: Harris, William S., et al.
Publicado: (2018)

Effectiveness of blood pressure-lowering drug treatment by levels of absolute risk: post hoc analysis of the Australian National Blood Pressure Study
por: Ho, Chau Le Bao, et al.
Publicado: (2018)

Blood pressure-lowering and cardiovascular effects of plumbagin in rats: An insight into the underlying mechanisms
por: Ahmad, Maira, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ddmisrsuqelbgj4e0i3g6gki2s